Back to Search
Start Over
Supplemental Figure 1 from Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental Figure 1: Overall survival of entire cohort from initiation of venetoclax.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....48f28a1d557f9e1d57cd60895ef876dc
- Full Text :
- https://doi.org/10.1158/1078-0432.22474646.v1